VIE/BIO (VIE/BIO)

Vienna Stock Exchange: VIE/BIO · EUR

€4.96

-0.02 (-0.4%)· Recorded snapshot

Market cap	19.8M
Shares out	4M
Volume	1,739
Beta	0.71

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Market cap: 19.8M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-31.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

S&P 500+0.6%

Nasdaq Composite-2.3%

Dow Jones Industrial Average+1.9%

Russell 2000+1.8%

All VIE/BIO indicators

Market & fundamental data

Available fields

113

Groups with data

Currency

EUR

Showing 113 of 113 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Austria
Country code	AT
Exchange	Vienna Stock Exchange
Financial currency	EUR
Financial report date	2024-03-31
First seen	2026-05-10
Fiscal year end	December
Industry	Packaged Foods
Is primary listing	Yes
ISIN number	ATBIOGENA005
Last refreshed	2026-10-29
Market cap	EUR 19.8M
Price	EUR 4.96
Price currency	EUR
Sector	Consumer Staples
SIC code	6799
Stock price date	2026-10-29
Symbol	vie/BIO
Website	https://biogenagroup.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (5Y)	-18.94x
FCF yield	-24.39%

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
ROA (5Y)	-20.77%
ROIC	-31.38%
ROIC (5Y)	-34.24%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Gross profit growth	-77.67%
Revenue growth	-45.81%
Revenue growth (Q)	-77.78%
Revenue growth (QoQ)	-63.62%
Revenue growth 3Y	-10.88%
Revenue growth 5Y	5.99%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -128,500
Depreciation and amortization	EUR 401,300
FCF per share	EUR -1.21
Financing cash flow	EUR -347,300
Free cash flow	EUR -4.8M
Investing cash flow	EUR -102,100
Net borrowing	EUR -929,700
Net cash flow	EUR -5.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Piotroski F-Score	0
Property, plant and equipment	EUR 5.8M
WACC	8.15%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	EUR 4.8M
Current liabilities	EUR 2.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend growth (3Y)	-20.63%
Dividend per share	EUR 0.00
Last dividend	EUR 0.05

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 4.32
1D price change	-0.4%
1M price change	-5.52%
1M total return	-5.52%
1W price change	-1.78%
1W total return	-1.78%
1Y price change	66.44%
1Y return CAGR	66.5%
1Y total return	66.44%
20-day SMA	EUR 5.13
200-day SMA	EUR 4.00
3M price change	-5.52%
3M total return	-5.52%
3Y price change	110.17%
3Y return CAGR	29.86%
3Y total return	119.03%
50-day SMA	EUR 5.19
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 6.10
52-week high date	2026-07-23
52-week low	EUR 2.50
52-week low date	2026-05-04
5Y price change	62.62%
5Y return CAGR	12.36%
5Y total return	79.07%
6M price change	66.44%
6M total return	66.44%
All-time high	EUR 7.55
All-time high date	2020-11-30
All-time low	EUR 1.40
All-time low date	2024-10-04
Average true range (ATR)	EUR 0.14
Average volume	923
Beta (1Y)	0.05
Beta (2Y)	-0.05
Beta (5Y)	0.71
Change from 52-week high	-18.69%
Change from 52-week low	98.4%
Change from all-time high	-34.3%
Change from all-time low	254.29%
Change from open	-2.75%
Day's gap	2.41%
Dollar volume	EUR 8,625
High price	EUR 5.10
Low price	EUR 4.90
Monthly RSI	74.37
Open price	EUR 5.10
Position in 52-week range	30%
Previous close	EUR 4.98
Price vs 150-day SMA	14.81%
Price vs 20-day SMA	-3.35%
Price vs 200-day SMA	23.94%
Price vs 50-day SMA	-4.36%
Relative volume	1.88
RSI	39.13
Sharpe ratio	1.14
Sharpe ratio (3Y)	0.65
Sharpe ratio (5Y)	0.39
Sortino ratio	2.01
Sortino ratio (3Y)	1.18
Sortino ratio (5Y)	0.77
Volume	1.7K
Weekly RSI	62.03
YTD price change	65.33%
YTD total return	65.33%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares outstanding	4M

Deeper analysis on VIE/BIO

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/BIO report

Is a complete VIE/BIO research report available?

No complete published report is available for vie/BIO (VIE/BIO) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/BIO (VIE/BIO)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/BIO

Valuation

Profitability

Trading

Next earnings

Sector percentile context

All VIE/BIO indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/BIO

Frequently asked questions